ALLIANCEBERNSTEIN L.P. - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 101 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 1.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$553,000
-12.1%
162,790
-2.7%
0.00%
Q2 2018$629,000
+0.3%
167,310
+9.1%
0.00%
Q1 2018$627,000
-2.3%
153,350
+11.0%
0.00%
Q4 2017$642,000
-57.5%
138,150
-35.0%
0.00%
-100.0%
Q3 2017$1,510,000
+8.9%
212,640
+11.0%
0.00%0.0%
Q2 2017$1,386,000
+63.4%
191,650
+39.2%
0.00%0.0%
Q1 2017$848,000
-3.1%
137,640
-7.8%
0.00%0.0%
Q4 2016$875,000
+10.3%
149,3400.0%0.00%0.0%
Q3 2016$793,000
-25.6%
149,340
-7.3%
0.00%0.0%
Q2 2016$1,066,000
+41.8%
161,0400.0%0.00%0.0%
Q1 2016$752,000
-15.7%
161,040
-8.8%
0.00%0.0%
Q4 2015$892,000
+43.6%
176,5400.0%0.00%0.0%
Q3 2015$621,000
-64.8%
176,540
-0.1%
0.00%0.0%
Q2 2015$1,763,000
-22.3%
176,700
-0.9%
0.00%
-50.0%
Q1 2015$2,270,000
-9.2%
178,300
+0.9%
0.00%0.0%
Q4 2014$2,500,000
-0.3%
176,700
-3.1%
0.00%0.0%
Q3 2014$2,507,000
-10.6%
182,3000.0%0.00%0.0%
Q2 2014$2,804,000
+8.6%
182,300
+20.3%
0.00%0.0%
Q1 2014$2,583,000
+31.4%
151,600
-0.2%
0.00%0.0%
Q4 2013$1,966,000
+29.9%
151,839
+1.4%
0.00%
+100.0%
Q3 2013$1,513,000
+35.2%
149,802
+0.0%
0.00%0.0%
Q2 2013$1,119,000149,8000.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
Finepoint Capital LP 1,605,800$16,026,0004.65%
Baupost Group 25,791,678$257,401,0004.29%
1492 Capital Management LLC 264,297$2,638,0001.67%
Cormorant Asset Management, LP 826,000$8,243,0001.10%
FALCON POINT CAPITAL, LLC 251,137$2,506,0000.85%
OAK RIDGE INVESTMENTS LLC 3,291,711$32,851,0000.70%
Knoll Capital Management, LLC 200,000$1,996,0000.64%
Rhenman & Partners Asset Management AB 534,000$5,329,0000.64%
Old West Investment Management, LLC 79,667$795,0000.55%
THREE BAYS CAPITAL LP 1,284,000$12,814,0000.53%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders